{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:43:33Z","timestamp":1764175413310,"version":"3.41.2"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Women in sub-Saharan Africa (SSA) experience the world's highest rates of both HIV infection and unintended pregnancy. The Dual Prevention Pill (DPP) is a novel multipurpose prevention technology (MPT) that co-formulates HIV pre-exposure prophylaxis (PrEP) and combined hormonal oral contraception into a single daily pill. As a dual indication product, the DPP may be preferred by women facing these overlapping health risks. However, most SSA countries face severe healthcare resource constraints. Research is needed to assess whether, in what populations, and in what use cases the DPP would be cost-effective.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We augmented an agent-based SSA HIV model with maternal health parameters including unintended pregnancy, abortion, and maternal mortality. Based on a previous market analysis, we assumed a primary DPP user population of current oral contraceptive users ages 25\u201349, and alternative user populations in different risk groups (age 15\u201324, sex workers, HIV-serodiscordant couples) and baseline product use profiles (unmet need for contraception, oral PrEP use, condom use). In three geographies (western Kenya, Zimbabwe, South Africa), we estimated HIV infections averted, pregnancies averted, disability-adjusted life-years (DALYs) averted, and the incremental cost-effectiveness ratio (ICER) over a 30-year time horizon, assuming equivalent adherence to the DPP as to oral contraceptives, higher adherence, or lower adherence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The DPP is likely to be a cost-effective alternative to oral PrEP among users in need of contraception. Among women not already using PrEP, the DPP is likely to be cost-saving in sex workers and serodiscordant couples. The DPP is unlikely to be cost-effective in oral contraceptive users in the general population. Switching from oral contraception to the DPP could be net harmful in some settings and populations if it were to substantially reduces adherence to oral contraception. Results were robust to a range of time horizons or discount rates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The DPP has the potential to be cost-effective and cost-saving in populations at substantial HIV risk. Outcomes are sensitive to adherence, implying that effective counseling and decision-making tools for users considering the DPP will be essential. More research is needed to understand real-life adherence patterns and ensure health benefits achieved from contraception alone are not lost.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frph.2023.1144217","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T11:49:34Z","timestamp":1684324174000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis"],"prefix":"10.3389","volume":"5","author":[{"given":"Masabho P.","family":"Milali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Resar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kaftan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adebanjo","family":"Olowu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrida","family":"Platais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bershteyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"year":"","key":"B2"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.667823","article-title":"Integrating oral PrEP into family planning services for women in sub-saharan Africa: findings from a multi-country landscape analysis","volume":"3","author":"Bhavaraju","year":"2021","journal-title":"Front Reprod Health"},{"key":"B4","article-title":"Adding it up: investing in sexual and reproductive health 2019\u2014methodology report","author":"Riley","year":"2020","journal-title":"Guttmacher Inst"},{"year":"","key":"B5"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1152","DOI":"10.1016\/S2214-109X(20)30315-6","article-title":"Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990\u20132019","volume":"8","author":"Bearak","year":"2020","journal-title":"Lancet Glob Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.2105\/AJPH.2015.302816","article-title":"How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize \u201ctruvada whores.\u201d","volume":"105","author":"Calabrese","year":"2015","journal-title":"Am J Public Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1007\/s10461-022-03721-6","article-title":"Prevalence and risk factors of PrEP use stigma among adolescent girls and young women in Johannesburg, South Africa and mwanza, Tanzania participating in the EMPOWER trial","volume":"26","author":"Munthali","year":"2022","journal-title":"AIDS Behav"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e25463","DOI":"10.1002\/jia2.25463","article-title":"The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study","volume":"23","author":"Velloza","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e904","DOI":"10.1016\/S2214-109X(19)30200-1","article-title":"Trends in contraceptive prevalence rates in sub-saharan Africa since the 2012 London summit on family planning: results from repeated cross-sectional surveys","volume":"7","author":"Ahmed","year":"2019","journal-title":"Lancet Glob Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2989\/16085906.2021.1872663","article-title":"Exploring male condom use among women in South Africa: a review of the literature","volume":"20","author":"Maharajh","year":"2021","journal-title":"Afr J AIDS Res AJAR"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.682689","article-title":"The promise of the dual prevention pill: a framework for development and Introduction","volume":"3","author":"Friedland","year":"2021","journal-title":"Front Reprod Health"},{"year":"","key":"B13"},{"year":"","key":"B14"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e83193","DOI":"10.1371\/journal.pone.0083193","article-title":"How much demand for new HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa","volume":"8","author":"Terris-Prestholt","year":"2013","journal-title":"PLOS ONE"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10461-019-02715-1","article-title":"Efficacy is not everything: eliciting Women's Preferences for a vaginal HIV prevention product using a discrete-choice experiment","volume":"24","author":"Browne","year":"2020","journal-title":"AIDS Behav"},{"key":"B17","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/QAI.0000000000001945","article-title":"Young Women's Stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa","volume":"80","author":"Minnis","year":"2019","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e25451","DOI":"10.1002\/jia2.25451","article-title":"Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries","volume":"23","author":"Pretorius","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e353\u201362","DOI":"10.1016\/S2352-3018(22)00029-7","article-title":"Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-saharan Africa: a modelling study","volume":"9","author":"Phillips","year":"2022","journal-title":"Lancet HIV"},{"key":"B20","doi-asserted-by":"publisher","first-page":"fty059","DOI":"10.1093\/femspd\/fty059","article-title":"Implementation and applications of EMOD, an individual-based multi-disease modeling platform","volume":"76","author":"Bershteyn","year":"2018","journal-title":"Pathog Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/QAI.0000000000002684","article-title":"Predicting HIV incidence in the SEARCH trial: a mathematical modeling study","volume":"87","author":"Jewell","year":"2021","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"B22","doi-asserted-by":"publisher","first-page":"20130613","DOI":"10.1098\/rsif.2013.0613","article-title":"Age-dependent partnering and the HIV transmission chain: a microsimulation analysis","volume":"10","author":"Bershteyn","year":"2013","journal-title":"J R Soc Interface"},{"key":"B23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/inthealth\/ihw010","article-title":"Age-targeted HIV treatment and primary prevention as a \u201cring fence\u201d to efficiently interrupt the age patterns of transmission in generalized epidemic settings in South Africa","volume":"8","author":"Bershteyn","year":"2016","journal-title":"Int Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.12688\/gatesopenres.13220.1","article-title":"The impact of the program for medical male circumcision on HIV in South Africa: analysis using three epidemiological models","volume":"5","author":"Korenromp","year":"2021","journal-title":"Gates Open Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e25527","DOI":"10.1016\/S2352-3018(22)00029-7","article-title":"Impact along the HIV pre-exposure prophylaxis \u201ccascade of prevention\u201d in western Kenya: a mathematical modelling study","author":"Bershteyn","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1016\/S2214-109X(22)00310-2","article-title":"Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models","volume":"10","author":"Bershteyn","year":"2022","journal-title":"Lancet Glob Health"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.503555","article-title":"Where are the newly diagnosed HIV positives in Kenya? Time to consider geo-spatially guided targeting at a finer scale to reach the \u201cfirst 90.\u201d","author":"Waruru","year":"2021","journal-title":"Front Public Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/bmjsrh-2020-200662","article-title":"Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake","volume":"47","author":"Begg","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"B29","article-title":"A review on hill climbing optimization methodology","volume-title":"Recent Trends in Management and Commerce","author":"Chinnasamy","year":"2022"},{"key":"B30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1023\/B:HEUR.0000034712.48917.a9","article-title":"Analyzing the performance of generalized hill climbing algorithms","volume":"10","author":"Jacobson","year":"2004","journal-title":"J Heuristics"},{"key":"B31","first-page":"724","article-title":"Roulette sampling for cost-sensitive learning","volume-title":"Machine learning: ECML","author":"Sheng","year":"2007"},{"journal-title":"PrEPWatch","article-title":"Developing and introducing a dual prevention pill- oral PrEP & oral contraception for HIV and pregnancy prevention","year":"","key":"B32"},{"journal-title":"PrEPWatch","article-title":"Frequently asked questions about the dual prevention pill","year":"","key":"B33"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1002885","DOI":"10.1371\/journal.pmed.1002885","article-title":"Integrating preexposure prophylaxis delivery in routine family planning clinics: a feasibility programmatic evaluation in Kenya","volume":"16","author":"Mugwanya","year":"2019","journal-title":"PLOS Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/padr.12027","article-title":"The impact of contraceptive use and abortion on fertility in sub-saharan Africa: estimates for 2003\u20132014","volume":"43","author":"Singh","year":"2017","journal-title":"Popul Dev Rev"},{"key":"B36","article-title":"Contraceptive failure rates in the developing world: an analysis of demographic and health survey data in 43 countries","author":"Polis","year":"2016","journal-title":"Guttmacher Institute"},{"key":"B37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1363\/3705811","article-title":"Contraceptive discontinuation and unintended pregnancy: an imperfect relationship","volume":"37","author":"Curtis","year":"2011","journal-title":"Int Perspect Sex Reprod Health"},{"key":"B38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/QAD.0000000000002486","article-title":"The impact of self-selection based on HIV risk on the cost-effectiveness of preexposure prophylaxis in South Africa","volume":"34","author":"Jamieson","year":"2020","journal-title":"AIDS"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3450-x","article-title":"Randomized evaluation and cost-effectiveness of HIV and sexual and reproductive health service referral and linkage models in Zambia","volume":"16","author":"Hewett","year":"2016","journal-title":"BMC Public Health"},{"year":"","key":"B40"},{"year":"","key":"B41"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0197485","DOI":"10.1371\/journal.pone.0197485","article-title":"The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in western cape province, South Africa","volume":"13","author":"Lince-Deroche","year":"2018","journal-title":"PLOS ONE"},{"key":"B43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0167-6296(97)00005-2","article-title":"Disability-adjusted life years: a critical review","volume":"16","author":"Anand","year":"1997","journal-title":"J Health Econ"},{"key":"B44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/heapol\/16.3.326","article-title":"Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis","volume":"16","author":"Rushby","year":"2001","journal-title":"Health Policy Plan"},{"key":"B45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00042737-200406000-00003","article-title":"Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls","volume":"16","author":"Bambha","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.socscimed.2005.10.023","article-title":"Incremental cost-effectiveness ratios (ICERs): the silence of the lambda","volume":"62","author":"Gafni","year":"2006","journal-title":"Soc Sci Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0190283","DOI":"10.1371\/journal.pone.0190283","article-title":"Reflecting the real value of health care resources in modelling and cost-effectiveness studies\u2014the example of viral load informed differentiated care","volume":"13","author":"Revill","year":"2018","journal-title":"PLOS ONE"},{"year":"","key":"B48"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e000964","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data","volume":"3","author":"Ochalek","year":"2018","journal-title":"BMJ Glob Health"},{"key":"B50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11904-020-00533-y","article-title":"Understanding, contextualizing, and addressing PrEP stigma to enhance PrEP implementation","volume":"17","author":"Calabrese","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/apc.2014.0142","article-title":"Knowledge, attitudes, and likelihood of Pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV","volume":"29","author":"Auerbach","year":"2015","journal-title":"AIDS Patient Care STDs"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0000762","DOI":"10.1371\/journal.pgph.0000762","article-title":"Knowledge and attitudes about HIV pre-exposure prophylaxis: evidence from in-depth interviews and focus group discussions with policy makers, healthcare providers, and end-users in Lesotho","volume":"2","author":"Geldsetzer","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1886455","DOI":"10.1080\/16549716.2021.1886455","article-title":"Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts","volume":"14","author":"Shamu","year":"2021","journal-title":"Glob Health Action"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e25883","DOI":"10.1002\/jia2.25883","article-title":"Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta-analysis of global data","volume":"25","author":"Sun","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2101731","DOI":"10.1080\/16549716.2022.2101731","article-title":"Survival patterns of neonates born to adolescent mothers and the effect of pregnancy intentions and marital status on newborn survival in Kenya, Uganda, and Tanzania","volume":"15","author":"Ochieng Arunda","year":"","journal-title":"Glob Health Action"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0205487","DOI":"10.1371\/journal.pone.0205487","article-title":"Reassessing pregnancy intention and its relation to maternal, perinatal and neonatal outcomes in a low-income setting: a cohort study","volume":"13","author":"Hall","year":"2018","journal-title":"PLOS ONE"},{"key":"B57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12963-020-00227-y","article-title":"Pregnancy intention data completeness, quality and utility in population-based surveys: eN-INDEPTH study","volume":"19","author":"Yargawa","year":"2021","journal-title":"Popul Health Metr"},{"year":"","author":"Pregnancy","key":"B58"},{"key":"B59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1728-4465.2008.00148.x","article-title":"The effects of unintended pregnancy on infant, child, and parental health: a review of the literature","volume":"39","author":"Gipson","year":"2008","journal-title":"Stud Fam Plann"},{"year":"","key":"B60"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1016\/S2214-109X(19)30163-9","article-title":"National, regional, and global levels and trends in neonatal mortality between 1990 and 2017, with scenario-based projections to 2030: a systematic analysis","volume":"7","author":"Hug","year":"2019","journal-title":"Lancet Glob Health"},{"key":"B62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ogrm.2014.01.007","article-title":"Non-oral contraception","volume":"24","author":"Black","year":"2014","journal-title":"Obstet Gynaecol Reprod Med"},{"year":"","key":"B63"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2023.1144217\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T11:49:50Z","timestamp":1684324190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2023.1144217\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":63,"alternative-id":["10.3389\/frph.2023.1144217"],"URL":"https:\/\/doi.org\/10.3389\/frph.2023.1144217","relation":{},"ISSN":["2673-3153"],"issn-type":[{"type":"electronic","value":"2673-3153"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"article-number":"1144217"}}